Ann J. Melvin

2.2k total citations
57 papers, 1.6k citations indexed

About

Ann J. Melvin is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Ann J. Melvin has authored 57 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Infectious Diseases, 24 papers in Virology and 11 papers in Epidemiology. Recurrent topics in Ann J. Melvin's work include HIV/AIDS Research and Interventions (28 papers), HIV/AIDS drug development and treatment (24 papers) and HIV Research and Treatment (23 papers). Ann J. Melvin is often cited by papers focused on HIV/AIDS Research and Interventions (28 papers), HIV/AIDS drug development and treatment (24 papers) and HIV Research and Treatment (23 papers). Ann J. Melvin collaborates with scholars based in United States, United Kingdom and France. Ann J. Melvin's co-authors include Kathleen M. Mohan, Lisa M. Frenkel, Nicole H. Tobin, James I. Mullins, Sarah Holte, Laurie Penix, Paul F. Lewis, Gerald H. Learn, David B. Lewis and Susan Bort and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Ann J. Melvin

56 papers receiving 1.5k citations

Peers

Ann J. Melvin

VIROL

EPIDE

IMMUN

Rodolphe Thiébaut France

Silvia Nozza Italy

Josep M. Gatell Spain

Elizabeth S. Machado Brazil

Alain Lafeuillade France

Hans Norrgren Sweden

Maria Franca Pirillo Italy

Marcelo Losso Argentina

Adrián Curran Spain

Knut Lidman Sweden

Rodolphe Thiébaut France

Ann J. Melvin

745 ×0.8

692 ×0.9

VIROL

519 ×1.3

EPIDE

179 ×0.5

IMMUN

211 ×0.9

Citations per year, relative to Ann J. Melvin Ann J. Melvin (= 1×) peers Rodolphe Thiébaut

Countries citing papers authored by Ann J. Melvin

Since Specialization

Citations

This map shows the geographic impact of Ann J. Melvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann J. Melvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann J. Melvin more than expected).

Fields of papers citing papers by Ann J. Melvin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann J. Melvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann J. Melvin. The network helps show where Ann J. Melvin may publish in the future.

Co-authorship network of co-authors of Ann J. Melvin

This figure shows the co-authorship network connecting the top 25 collaborators of Ann J. Melvin. A scholar is included among the top collaborators of Ann J. Melvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann J. Melvin. Ann J. Melvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baker, Mark R., Xing Wang, & Ann J. Melvin. (2025). Timing of congenital cytomegalovirus diagnosis and missed opportunities. Frontiers in Pediatrics. 13. 1475121–1475121. 1 indexed citations

White, Michelle M., et al.. (2023). A Cross-Sectional Survey of Pediatric Infectious Disease Physicians’ Approach to Congenital Cytomegalovirus Infection. International Journal of Neonatal Screening. 9(2). 17–17. 8 indexed citations

Hassell, Laurie, Ann J. Melvin, Christopher H. Goss, et al.. (2019). Feasibility of connecting regional research programs to national multisite trials emanating from the CTSA Trial Innovation Network. SHILAP Revista de lepidopterología. 4(2). 75–80. 1 indexed citations

Holbein, M. E. Blair, Barbara Hammack, Ann J. Melvin, & Tamsin A. Knox. (2019). Via media: Role and responsibilities of the independent safety officer. SHILAP Revista de lepidopterología. 3(4). 147–151. 1 indexed citations

Vora, Surabhi B, Catherine Amlie‐Lefond, Francisco A. Perez, & Ann J. Melvin. (2018). Varicella-Associated Stroke. The Journal of Pediatrics. 199. 281–281.e1. 1 indexed citations

Agwu, Allison L., Meredith G. Warshaw, Elizabeth J. McFarland, et al.. (2017). Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial. PLoS ONE. 12(6). e0178075–e0178075. 11 indexed citations

Stein, Mark A., et al.. (2015). Research START: A Multimethod Study of Barriers and Accelerators of Recruiting Research Participants. Clinical and Translational Science. 8(6). 647–654. 17 indexed citations

Harrison, Linda, Ann J. Melvin, Susan A. Fiscus, et al.. (2015). HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds. JAIDS Journal of Acquired Immune Deficiency Syndromes. 70(1). 42–53. 7 indexed citations

Wolf, Elizabeth R., et al.. (2015). Health Outcomes of International HIV-infected Adoptees in the US. The Pediatric Infectious Disease Journal. 35(4). 422–427. 13 indexed citations

10.

Melvin, Ann J., et al.. (2012). Role for CTSAs in Leveraging a Distributed Research Infrastructure to Engage Diverse Stakeholders in Emergent Research Policy Development. Clinical and Translational Science. 6(1). 57–59. 3 indexed citations

11.

Castro, Hannah, Alexandra Compagnucci, Carlo Giaquinto, et al.. (2011). First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. The Lancet Infectious Diseases. 11(4). 273–283. 101 indexed citations

12.

Wagner, Thor A., Nicole H. Tobin, Min Xu, et al.. (2009). Increased mutations in Env and Pol suggest greater HIV-1 replication in sputum-derived viruses compared with blood-derived viruses. AIDS. 23(8). 923–928. 8 indexed citations

13.

Melvin, Ann J., et al.. (2004). Rapid HIV Type 1 Testing of Women Presenting in Late Pregnancy with Unknown HIV Status in Lima, Perú. AIDS Research and Human Retroviruses. 20(10). 1046–1052. 11 indexed citations

14.

Melvin, Ann J., et al.. (2002). Efficacy and Toxicity of Antiretroviral Therapy Using 4 or More Agents. Archives of Pediatrics and Adolescent Medicine. 156(6). 568–568. 14 indexed citations

15.

Melvin, Ann J., et al.. (2001). Metabolic Abnormalities in HIV Type 1-Infected Children Treated and Not Treated with Protease Inhibitors. AIDS Research and Human Retroviruses. 17(12). 1117–1123. 44 indexed citations

16.

Melvin, Ann J.. (1999). ANTI-RETROVIRAL THERAPY FOR HIV-INFECTED CHILDREN-TOWARD MAXIMAL EFFECTIVENESS. The Pediatric Infectious Disease Journal. 18(8). 723–724. 9 indexed citations

17.

Melvin, Ann J., Allen G. Rodrigo, Kathleen M. Mohan, et al.. (1999). HIV-1 Dynamics in Children. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 20(5). 468–473. 34 indexed citations

18.

Frenkel, Lisa M., Mary Kathryn Cowles, David E. Shapiro, et al.. (1997). Analysis of the Maternal Components of the AIDS Clinical Trial Group 076 Zidovudine Regimen in the Prevention of Mother‐to‐Infant Transmission of Human Immunodeficiency Virus Type 1. The Journal of Infectious Diseases. 175(4). 971–974. 32 indexed citations

19.

Melvin, Ann J., et al.. (1995). Hypomethylation of the interferon‐γ gene correlates with its expression by primary T‐lineage cells. European Journal of Immunology. 25(2). 426–430. 93 indexed citations

20.

Melvin, Ann J., et al.. (1971). THE CASH VALUE OF MOTORWAY POLLUTION. 66(777). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact